Overview

Exploring Efficacy of Intensive Rosuvastatin Treatment Peri-PCI in Chinese Patients With Non ST-segment Elevated Acute Coronary Syndrome(NSTE-ACS)

Status:
Unknown status

Trial end date:
2016-06-01

Target enrollment:

Participant gender:

Summary

This is a 30-day, randomized, open-label, 3-arm, parallel-group, multicenter study exploring efficacy of intensive rosuvastatin treatment peri-PCI in Chinese patients with NSTE-ACS.

Phase:

Phase 4

Details

Lead Sponsor:

Shanghai Zhongshan Hospital

Treatments:

Rosuvastatin Calcium